XIIDRA

Marca svizra · 701576 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
701576
Numer da la dumonda
50472/2017
Status
En vigur
Tip
Marca da pled
Deponida
16-01-2017
Registrada
28-04-2017
Publitgada
28-04-2017
Protegida fin ils
16-01-2027
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Augentropfen; pharmazeutische Präparate zur Behandlung des trockenen Auges.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 06-06-2024

    Transferì

    Owner
    Novartis AG, 4002 Basel → Bausch + Lomb Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin, Ireland 24, Ireland
    Representative
    Murgitroyd & Company, 4, rue du Commerce, 1204 Genève

    Published in Swissreg on 06.06.2024

  2. 24-10-2019

    Represchentant stritgà

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich (allontanà)

    Published in Swissreg on 24.10.2019

  3. 24-10-2019

    Transferì

    Owner
    SARcode Bioscience Inc., 300 Shire Way, Lexington, Massachusetts 02421, USA → Novartis AG, 4002 Basel

    Published in Swissreg on 24.10.2019

  4. 28-04-2017

    Registrà

    Published in Swissreg on 28.04.2017

Partidas

Possessura

Bausch + Lomb Ireland Limited

3013 Lake Drive, Citywest Business Campus, Dublin, Ireland 24, IE

Represententa

Murgitroyd & Company

4, rue du Commerce, 1204 Genève

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.